In many cases of malignant melanoma, the effect of targeted treatment is lost over time. A research team has now discovered that a factor secreted by tumor cells is responsible for the resistance. These findings could pave the way for more effective therapies.
Quelle: ScienceDaily | Immunsystem
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Molecular zip code draws killer T cells straight to brain tumors
- Innovative immunotherapy shows promise in early clinical trial for breast cancer
- Changes in blood cell production over the lifetime could impact leukemia outcomes
- Engineered immune cells may be able to tame inflammation
- New research on chronic inflammation explores potential treatments for chronic diseases and cancer
- DNA secreted by tumor cell extracellular vesicles prompts anti-metastatic immune response
- Immune T cells become exhausted in chronic fatigue syndrome patients
- Researchers design novel immunotherapy for brain cancer
- Pregnancy enhances natural immunity to block severe flu
- Newfound mechanism may explain why some cancer treatments boost risk of heart disease
